Rakicidin A : A Hypoxia-Selective Cytotoxin(Molecular and Cell Biology)
スポンサーリンク
概要
- 論文の詳細を見る
Hypoxia is a common feature of many solid tumors and contributes to their progression. Hypoxic cells in the tumor are not only involved in therapeutic resistance to chemotherapy and radiotherapy but are also relevant to tumor angiogenesis. To identify novel hypoxia-selective cytotoxins, we screened 20000 cultured broths of microorganisms and found that rakicidin A showed significant hypoxia-selective cytotoxicity. Rakicidin A was approximately 17.5-fold more cytotoxic under hypoxic than under normoxic conditions. CoCl_2 and antioxidants had no effect on the rakicidin A cytotoxicity under normoxic conditions and rakicidin A did not show the inhibitory effects on HIF-1 transcriptional activity under hypoxic conditions. Thus, although the action mechanism of the hypoxia-selective cytotoxicity of rakicidin A was unknown, our screening study suggested that rakicidin A acts as an antitumor agent for selective therapy against solid tumors.
- 公益社団法人日本薬学会の論文
- 2007-02-01
著者
-
Yamazaki Yohko
微生物化学研究会微生物化学研究センター沼津創薬医科学研究所
-
YAMAZAKI Yohko
Numazu Bio-Medical Research Institute, Microbial Chemistry Research Center
-
KUNIMOTO Setsuko
Numazu Bio-Medical Research Institute, Microbial Chemistry Research Center
-
IKEDA Daishiro
Numazu Bio-Medical Research Institute, Microbial Chemistry Research Center
-
Yamazaki Yoko
Numazu Bio-medical Research Institute Microbial Chemistry Research Center
-
Yamazaki Yohko
Numazu Bio-medical Research Institute Microbial Chemistry Research Center
-
Ikeda Daishiro
Numazu Bio-medical Research Institute Microbial Chemistry Research Center
-
Kunimoto S
Numazu Bio-medical Research Institute Microbial Chemistry Research Center
-
Kunimoto Setsuko
Numazu Bio-medical Research Institute Microbial Chemistry Research Center
-
山嵜 行由
School Of Pharmaceutical Sciences University Of Shizuoka
関連論文
- LIPASE-CATALYZED ENANTIOSYNTHESIS OF (R)- AND (S)-2-[BENZYL(PHENYL)AMINO]ETHYL 5-(5,5-DIMETHYL-2-OXO-1,3,2-DIOXAPHOSPHORINAN-2-YL)-1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3-PYRIDINECARBOXYLATE (NZ 105)
- DETERMINATION OF THE ABSOLUTE CONFIGURATION OF BIOLOGICALLY ACTIVE (S)-(-)-NB 818 AND ITS STRUCTURAL CORRELATION WITH THE STEREOSELECTIVITY OF THE CHANNEL BLOCKING ACTION
- Inhibitory Effect of Laidlomycin on Human Immunodeficiency Virus Replication
- Eulicin Inhibits Human Immunodeficiency Virus Infection and Replication
- Specific Inhibition of Hypoxia-inducible Factor (HIF)-1α Activation and of Vascular Endothelial Growth Factor (VEGF) Production by Flavonoids(Biochemistry/Molecular Biology)
- Chalcone and Stilbene Synthases Expressed in Eucaryotes Exhibit Reduced Cross-Reactivity in Vitro
- Anthracyclines, Small-Molecule Inhibitors of Hypoxia-Inducible Factor-1 Alpha Activation(Molecular and Cell Biology)
- HIF-1-Dependent VEGF Reporter Gene Assay by a Stable Transformant of CHO Cells
- Induction of p16/INK4a Gene Expression and Cellular Senescence by Toyocamycin(Biochemistry/Molecular Biology)
- Deoxynybomycin Is a Selective Anti-Tumor Agent Inducing Apoptosis and Inhibiting Topoisomerase I
- Identification of Active Substances from Streptomyces Culture Fluids Using p53-Independent Expression of p21/WAF1/Cip1 Gene and Their Mode of Action
- Kigamicins, Novel Antitumor Antibiotics I. Taxonomy, Isolation, Physico-chemical Properties and Biological Activities
- Decatromicins A and B, New Antibiotics Produced by Actinomadura sp. MK73-NF4 I. Taxonomy, Isolation, Physico-chemical Properties and Biological Activities
- A New Cytotoxic 2H-Pyran Compound Produced by Acid Treatment of the Fermentation Broth of Streptomyces Sp.
- Effect of Cytogenin, a Novel Immunomodulator, on Streptozotocin-induced Diabetes in Mice
- Asymmetric Synthesis of (R)-Nilvadipine and (S)-NB 818 via Regioselective Bromination of Chiral 1,4-Dihydropyridines as a Key Step and Enzymatic Resolution of Racemic 2-Hydroxymethyl-1,4-dihydropyridine Derivatives
- Lipase-Catalyzed Enantioselective Hydrolysis of Bis(acyloxymethyl) 1,4-Dihydro-3,5-pyridinedicarboxylates Leading to Optically Active Medicines
- Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation
- Kigamicins, Novel Antitumor Antibiotics II. Structure Determination
- Absolute Configuration of Kigamicins A, C and D
- Synthesis and Activity of Tyropeptin A Derivatives as Potent and Selective Inhibitors of Mammalian 20S Proteasome
- Rakicidin A : A Hypoxia-Selective Cytotoxin(Molecular and Cell Biology)
- The Decrease of Cytochrome c Oxidase Activity by 15-Deoxyspergualin Results in Enhancement of XTT Reduction in Cultured Cells
- Stimulation of Cellular XTT Reduction by Cytochrome Oxidase Inhibitors
- Rubratoxin A specifically and potently inhibits protein phosphatase 2A and suppresses cancer metastasis
- Augmentation of Cellular Immunity by Kigamicin D
- Antitumor Effect of Kigamicin D on Mouse Tumor Models
- A New Proteasome Inhibitor, TP-110, Induces Apoptosis in Human Prostate Cancer PC-3 Cells
- Inhibitory Activity of the Hypoxia-inducible Factor-1 Pathway by Tartrolone C
- Prevention of Neomycin-induced Nephrotoxic Event in Pig Proximal Tubular Epithelial Cell Line by Apolipoprotein E3
- Increased ABCB1 Expression in TP-110-Resistant RPMI-8226 Cells
- Inhibition of Nitric Oxide Synthase Induction by 15-Deoxyspergualin in a Cultured Macrophage Cell Line, J744A.1 Activated with IFN-γ and LPS
- NBRI17671, a new antitumor compound, produced by Acremonium sp. CR 17671
- NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716